| http://www.w3.org/ns/prov#value | - VI. We are applying our immunization model to better understand the anti-pathoangiogenic properties of CM101 which makes it applicable to rheumatoid arthritis, wound healing, reperfusion injury, spinal cord injury and other diseases driven by pathologic angiogenesis.
|
